Psychedelic drug MDMA faces questions as FDA considers approval for PTSD

FDA’s review of MDMA for PTSD highlights study bias and safety concerns

FDA advisors will meet June 4 to discuss and vote on the therapy's effectiveness.

Psychedelic drug MDMA faces questions as FDA considers approval for PTSD

By MATTHEW PERRONE AP Health Writer WASHINGTON (AP) — Federal health regulators are set to review the first request to approve the mind-altering club drug MDMA as a treatment for PTSD. The Food and Drug Administration posted its review of the drug on Friday, raising questions about its effectiveness and potential risks, including heart problems. The drug application is part of a decadeslong effort by advocates to move psychedelic drugs into the …

Psychedelic drug MDMA faces questions as FDA considers approval for PTSD

WASHINGTON (AP) — Federal health regulators are questioning the safety and evidence behind the first bid to use MDMA, the mind-altering club drug, as a treatment for PTSD, part of a decadeslong effort by advocates to move psychedelic drugs into the medical mainstream.The Food and Drug Administration posted its initial review of the drug Friday,...

Illegal ecstasy takes step toward becoming legal drug for PTSD

The first new PTSD drug in over 20 years is up for approval. It will require U.S. regulators to do something they've never done before: greenlight the mind-altering—and illegal—party drug known as ecstasy.

Psychoactive drugs like ketamine and MDMA are having a moment. The FDA will soon weigh in.

Drugs such as LSD, ketamine, mushrooms and MDMA can be powerful treatments for severe depression and PTSD, mounting evidence suggests — but not everyone is convinced.

Psychedelic Drug MDMA Faces Questions As FDA Considers Approval For PTSD - KFOR FM 101.5 1240 AM

Credit: MGNWASHINGTON (AP) — Federal health regulators are set to review the first request to approve the mind-altering club drug MDMA as a treatment for PTSD. The Food and Drug Administration posted its review of the drug on Friday, raising questions about its effectiveness and potential risks, including heart problems. The drug application is part of a decades-long effort by advocates to move psychedelic drugs into the medical mainstream. If a…